|
Resolution: standard / high Figure 6.
Electrophoretic mobility-shift assay employing cell nuclear extract from MCF7. (a) Gel shift analyses were performed with double-stranded oligonucleotides (27 bp) as
indicated: positive control probe containing the GATA3-binding element (GATA3-wt),
a mimetic wild-type MUC1 probe containing the predictive GATA3-binding site (MUC1-wt),
and a probe sequence with predictive GATA3-binding site mutations (MUC1-mut). (b) The presence of GATA3 was confirmed by supershift assay. Nuclear extract prepared
from MCF7 cells was preincubated with GATA3 antibody, and then incubated with the
mimetic wild-type MUC1 probe containing the GATA3-binding site (MUC1-wt). Arrows to
the right indicate the position of the free probe (FP), the probe–nuclear-protein
complex (Complex), and the specifically retarded protein–GATA3-antibody–probe complex
(Supershift).
Abba et al. Breast Cancer Research 2006 8:R64 doi:10.1186/bcr1617 |